1208424

Novartis Pharmaceuticals Corporation — FEI 2210396

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
East Hanover, NJ (United States)

Additional Details

Sponsor, Contract Research Organization